Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

You may be eligible if

• Patients with metastatic colorectal adenocarcinoma who have failed one prior course of chemotherapy.
• Patients must have at least one measurable tumor.
• Patients may not have received prior treatment with oxaliplatin.